Qualigen Therapeutics, Inc. Common Stock (QLGN) Return on Equity (ROE) (2021 - 2025)
Qualigen Therapeutics, Inc. Common Stock (QLGN) Return on Equity (ROE) from Mar 31, 2021 to Sep 30, 2025. The TTM Qualigen Therapeutics, Inc. Common Stock (QLGN) Return on Equity (ROE) is -5.29%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Qualigen Therapeutics, Inc. Common Stock (QLGN)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2024 | -233.58% | -135.65% |
| 2023 | 655.24% | -373.25% |
| 2022 | -239.79% | +121.84% |
| 2021 | -108.09% | N/A |